/person/aspinall-mara-roche-201109-genzyme-genetics-labcorp-group-2001-4885.html

Advertisement

Banner Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Person › Details

Mara G. Aspinall (Genzyme Genetics)

Aspinall, Mara G. (Roche 201109– President Ventana Medical before On-Q-ity founder + CEO before Genzyme)

 

Products Product diagnostics (medical/biological)
  Product 2 oncology
     

Ventana Medical Systems, Inc.. (8/1/11). "Press Release: Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.". Tuscon, AZ.

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the appointment of Mara Aspinall to the role of President, Ventana Medical Systems, Inc. Aspinall was most recently Founder, President, and CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumor cell technology.

Prior to this, Aspinall spent twelve years with Genzyme Corporation where she held senior leadership roles such as President of Genzyme Genetics and President of Pharmaceuticals. While at Genzyme, her considerable international experience spanned operations, R&D, mergers and acquisitions, strategic partnerships, product and market positioning and expansion, as well as financial planning and performance.

"Mara brings a track record of success at Genzyme and a wealth of diagnostics industry experience to this important role," said Daniel O'Day, COO Roche Diagnostics. "In line with Ventana's mission to improve the lives of all patients afflicted with cancer, she will be working closely across Roche divisions and with our business partners with a focus on enabling our customers to deliver the absolute highest standards of patient care and business performance available globally."

A frequent industry speaker, Aspinall has spearheaded industry-wide outreach initiatives to better educate the health care community and policymakers about genetics, genomics, and personalized medicine. She was a member of the Secretary of Health and Human Services' former Advisory Council on Genetics in the Obama and Bush Administrations. She is also a Co-Founder of the European Personalized Medicine Association. Aspinall holds an MBA from Harvard Graduate School of Business Administration and a Bachelor's of Arts in International Relations from Tufts University. She begins her new role at Ventana in September 2011.


About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's "Smart Systems" - intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors - support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving personalized medicine through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.

VENTANA and the VENTANA logo are trademarks of Roche.


VMSI Media Relations

Jacqueline Bucher
Director, Corporate Communications
Phone: 520-877-7288
e-mail: jacquie.bucher@ventana.roche.com


   
Record changed: 2012-02-13

Advertisement

Banner Biovision 2014 Lyon France June 600x60px


More documents for Mara G. Aspinall


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Banner Biovision 2014 Lyon France June 600x60px




» top

Advertisements

Banner EBD Group BIO Europe 2013 BEU Frankfurt November 120x180px Banner BIO Deutschland CFO Summit 2014 Berlin May 120x120px Banner Biovision 2014 Lyon France June 120x80px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px